GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Overview Fund Activity
Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

93 hedge funds and large institutions have $525M invested in G1 Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 30 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
-22
Holders Change %
-19.13%
% of All Funds
2.08%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
39
Reduced
30
Closed
37
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
+$669K

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$72.2M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$19.7M
3
State Street
3
State Street
Massachusetts
$23.2M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$107M
5
CAM
5
Cormorant Asset Management
Massachusetts
$19M

Top Sellers

1
HIM
1
Hillhouse Investment Management
Cayman Islands
$0
2
EA
2
Emerald Advisers
Pennsylvania
$0
3
EMFAT
3
Emerald Mutual Fund Advisers Trust
Pennsylvania
$0
4
DM
4
Deerfield Management
New York
$0
5
MCM
5
Marsico Capital Management
Colorado
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$107M +$6.91M +361,091 +7%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$72.2M +$10.7M +560,428 +17%
BlackRock
3
BlackRock
New York
$37.6M +$2.43M +126,892 +7%
Vanguard Group
4
Vanguard Group
Pennsylvania
$32.5M -$346K -18,081 -1%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$32.5M -$4.64M -242,213 -12%
Franklin Resources
6
Franklin Resources
California
$23.6M +$1.36M +70,900 +6%
State Street
7
State Street
Massachusetts
$23.2M +$7.52M +392,737 +48%
Capital World Investors
8
Capital World Investors
California
$23.1M -$153K -8,000 -0.7%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$20.8M -$3.43M -178,972 -14%
JPMorgan Chase & Co
10
JPMorgan Chase & Co
New York
$19.7M +$9.54M +498,095 +94%
CAM
11
Cormorant Asset Management
Massachusetts
$19M +$6.78M +353,806 +55%
HA
12
HHLR Advisors
Cayman Islands
$18.2M +$18.2M +949,431 New
BB
13
BB Biotech
Switzerland
$12.9M +$4.72M +246,607 +58%
Marshall Wace
14
Marshall Wace
United Kingdom
$7.4M +$6.57M +342,990 +788%
Northern Trust
15
Northern Trust
Illinois
$5.39M +$371K +19,360 +7%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$5.34M +$500K +26,098 +10%
Bank of America
17
Bank of America
North Carolina
$4.86M +$5.38K +281 +0.1%
VOYA Investment Management
18
VOYA Investment Management
Georgia
$4.65M -$2.13M -111,039 -31%
Morgan Stanley
19
Morgan Stanley
New York
$3.95M +$3.25M +169,488 +461%
RPAM
20
Rhenman & Partners Asset Management
Sweden
$3.31M +$3.31M +172,820 New
Citadel Advisors
21
Citadel Advisors
Florida
$3.29M +$3.2M +167,210 +3,600%
UBS AM
22
UBS AM
Illinois
$2.59M -$280K -14,639 -10%
Capital International Investors
23
Capital International Investors
California
$2.59M -$2.49M -130,000 -49%
Charles Schwab
24
Charles Schwab
California
$2.59M +$231K +12,042 +10%
BBA
25
Baker Bros. Advisors
New York
$2.44M – – –
1
2 3 4 5